08/19/2025
4:15 PM | Kairos Pharma (Filer)
| Form 424B3 | |
08/14/2025
8:12 PM | ARMISTICE CAPITAL, LLC (Filed by)
Kairos Pharma (Subject)
| Form SCHEDULE 13G/A | |
08/12/2025
2:34 PM | Kairos Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/28/2025
11:43 AM | Kairos Pharma (Filer)
| Form 10-K/A | |
07/15/2025
8:11 AM | Kairos Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/03/2025
7:20 AM | Kairos Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/16/2025
2:38 PM | Kairos Pharma (Filer)
| Form DEFR14A | |
05/15/2025
2:19 PM | ARMISTICE CAPITAL, LLC (Filed by)
Kairos Pharma (Subject)
| Form SCHEDULE 13G | |
05/14/2025
5:34 AM | Kairos Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/06/2025
11:20 AM | Kairos Pharma (Filer)
| Form PRER14A | |
04/28/2025
4:28 PM | Kairos Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for KAPA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Kairos Pharma and its competitors with MarketBeat's FREE daily newsletter. |
04/25/2025
4:13 PM | Kairos Pharma (Filer)
| Form 424B3 | |
04/24/2025
11:15 PM | Kairos Pharma (Filer)
| Form EFFECT | |
04/24/2025
7:30 AM | Kairos Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/21/2025
6:09 PM | Kairos Pharma (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
04/15/2025
4:30 PM | Kairos Pharma (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
04/07/2025
7:30 AM | Bhowmick Neil (Reporting)
Kairos Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2025
6:30 AM | Kairos Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/26/2025
6:05 AM | Kairos Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/24/2025
5:51 PM | Kairos Pharma (Issuer)
Yu John S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/24/2025
5:52 PM | Kairos Pharma (Issuer)
Murali Ramachandran (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/10/2025
3:45 PM | Kairos Pharma (Filer)
| Form DEF 14C | |
02/06/2025
8:00 AM | Kairos Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/04/2025
11:15 PM | Kairos Pharma (Filer)
| Form EFFECT | |
02/05/2025
5:15 AM | Kairos Pharma (Filer)
| Form 424B3 | |
01/29/2025
6:22 AM | Kairos Pharma (Filer)
| Form PRE 14C | |
01/29/2025
5:39 AM | Kairos Pharma (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
01/17/2025
4:20 PM | Kairos Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/14/2025
8:41 AM | Kairos Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/25/2024
7:30 PM | Kairos Pharma (Issuer)
Murali Ramachandran (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/25/2024
5:03 AM | Kairos Pharma (Issuer)
Samuelson Doug (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2024
8:53 PM | Kairos Pharma (Issuer)
Yu John S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/19/2024
7:48 AM | Kairos Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
1:19 PM | Kairos Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/10/2024
4:30 PM | Kairos Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/04/2024
4:29 PM | Kairos Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/27/2024
4:10 PM | Kairos Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/27/2024
4:17 PM | Kairos Pharma (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
09/24/2024
8:00 PM | Bae Hyun W. (Reporting)
Kairos Pharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/24/2024
8:00 PM | Kairos Pharma (Issuer)
Yu John S (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/24/2024
8:00 PM | Kairos Pharma (Issuer)
Samuelson Doug (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
Capital Gains Tax Strategies for Seniors (Ad) Capital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holding investments longer to using tax-advantaged accounts and strategic loss offsetting, there are ways to reduce your exposure.
SmartAsset outlines three capital gains tax strategies for seniors and offers a free tool to connect you with vetted fiduciary financial advisors who can help tailor these tactics to your situation. Click here to see the three strategies and get matched with a financial advisor today. |
09/24/2024
8:00 PM | Kairos Pharma (Issuer)
Keyoung Hansoo Michael (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/24/2024
8:00 PM | Kairos Pharma (Issuer)
Murali Ramachandran (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/24/2024
8:00 PM | Kairos Pharma (Issuer)
MAZANET ROSEMARY (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/24/2024
8:00 PM | Bhowmick Neil (Reporting)
Kairos Pharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/24/2024
3:22 PM | Kairos Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/17/2024
3:15 PM | Kairos Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/17/2024
5:36 AM | Kairos Pharma (Filer)
| Form 424B4 | |
09/16/2024
11:15 PM | Kairos Pharma (Filer)
| Form EFFECT | |
09/12/2024
12:57 PM | Kairos Pharma (Filer)
| Form CERT | |
09/12/2024
11:44 AM | Kairos Pharma (Filer)
| Form 8-A12B | |
MarketBeat All Access